38098 Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices 

evolving COVID–19 vaccine 

development and regulatory processes. 

The Secretary of Health and Human 

Services has determined that COVID–19 

is a Public Health Emergency. A notice 

of this ACIP meeting has also been 

posted on CDC’s ACIP website at: http:// 

www.cdc.gov/vaccines/acip/index.html. 

In addition, CDC has sent notice of this 

ACIP meeting by email to those who 

subscribe to receive email updates about 

ACIP. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters To Be Considered: The agenda 

will include discussions on COVID–19 

vaccine safety. Agenda items are subject 

to change as priorities dictate. For more 

information on the meeting agenda visit 

https://www.cdc.gov/vaccines/acip/ 

meetings/meetings-info.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web; for more information on ACIP 

please visit the ACIP website: http://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: Written 

comments must be received on or before 

July 22, 2021. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children Program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the July 22, 2021, 

ACIP meeting must submit a request at 

http://www.cdc.gov/vaccines/acip/ 

meetings/ no later than 11:59 p.m., EDT, 

July 20, 2021, according to the 

instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by 12:00 p.m., EDT, July 21, 2021. To 

accommodate the significant interest in 

participation in the oral public 

comment session of ACIP meetings, 

each speaker will be limited to 3 

minutes, and each speaker may only 

speak once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–15322 Filed 7–14–21; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21GO; Docket No. CDC–2021– 

0068] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Evaluating the use of EHMRs in 

health settings to improve 

organizational implementation and 

worker adoption during and after the 

COVID–19 pandemic. NIOSH proposes 

using surveys and interviews to 

understand how elastomeric half mask 

respirators (EHMRs) are being perceived 

and used by healthcare and first 

responder settings during the COVID–19 

pandemic. 

DATES: CDC must receive written 

comments on or before September 17, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0068 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices 38099 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Evaluating the use of EHMRs in 

health settings to improve 

organizational implementation and 

worker adoption during and after the 

COVID–19 pandemic—New—National 

Institute of Occupational Safety and 

Health (NIOSH), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

CDC/NIOSH is requesting approval of 

a new data collection for a period of two 

years under the project titled 

‘‘Evaluating the use of EHMRs in health 

settings to improve organizational 

implementation and worker adoption 

during and after the COVID–19 

pandemic.’’ The data collection 

activities were initiated under the 

Public Health Emergency PRA waiver. 

NIOSH has the responsibility to conduct 

research relating to innovative methods, 

techniques, and approaches dealing 

with occupational safety and health 

problems. Additionally, OSHA’s 

Emergency Temporary Standard (ETS) 

for COVID–19 in Healthcare released in 

June 2021 (29 CFR 1910, Subpart U) is 

facilitating the need for this work. 

Finally, during the nationwide shortage 

of filtering facepiece respirators (FFRs), 

the Food and Drug Administration 

(FDA) issued an emergency use 

authorization (EUA), allowing the use of 

all NIOSH-approved respiratory 

protective devices in healthcare settings 

during the pandemic—of which 

elastomeric half mask respirators 

(EHMRs) were included (85 FR 17335, 

March 27, 2020). This EUA was 

provided for alternative FFR use in 

healthcare settings to prevent wearer 

(i.e., worker) exposure to airborne 

particulates because of the COVID–19 

pandemic and the life-threatening 

illness it can cause (FDA, 2020). 

Currently, organizations are being 

confronted with the use of new 

respiratory protection and questions on 

how to best support its implementation 

during the pandemic. To that end, the 

purpose of this demonstration research 

study is to assess the integration of 

EHMRs in various healthcare and first 

responder settings and subsequently 

update and enhance EHMR best 

practices and implementation 

guidelines to encourage adoption and 

consequently, reduce PPE supply 

shortages during the current and future 

pandemics. 

This project is supported through a 

NIOSH Federal Register Notice (FRN) 

that posted in September 2020, titled, 

‘‘A National Elastomeric Half Mask 

Respirator (EHMR) Strategy for Use in 

Healthcare Settings During an Infectious 

Disease Outbreak/Pandemic.’’—Vol. 85, 

No. 178. The announcement requested 

information regarding the deployment 

and use of EHMRs in healthcare settings 

and first responder organizations during 

the COVID–19 crisis. 

This proposed study involves 

conducting surveys and interviews. 

Individual workers who receive EHMRs 

from their organization will have the 

option to voluntarily participate in a 

pre-/post-survey. Voluntary data 

collection at the organizational level 

with members of management will 

occur using an interview format that 

follows a semi-structured approach to 

capture information throughout the 

duration of NIOSH’s research study. 

Individual workers (via surveys) and 

organization management (via 

interviews) will participate in data 

collection activities over a period of 

approximately 4–9 months to assess 

perceptions, knowledge, attitudes, and 

experiences using EHMRs as well as 

best practices for adoption and 

implementation of EHMRs at their 

organizations. Individuals who are 

asked to respond are those who notified 

NIOSH of their interest of participating 

in the study. Respondents are expected 

to include a variety of job types 

including industrial hygienists, 

occupational health professionals, 

infection control professionals, 

physicians, nurse practitioners, nurses, 

infection preventionists, fire department 

chiefs, battalion chiefs, sheriffs, shift 

supervisors, firefighters, police officers, 

and paramedics. 

A multi-site approach is necessary to 

answer and further validate findings 

related to the study objectives. By 

conducting several studies at healthcare 

and first responder locations, NIOSH 

researchers can make the case for 

research progression, which enhances 

the reliability and validity of any 

revised guidance. 

NIOSH requests approval for a total of 

42,877 estimated burden hours. There 

are no costs to respondents other than 

their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Organizational manager/POC ....................... Informed Consent ................. 150 3 5/60 38 

Time 1 Interview ................... 150 1 45/60 113 

Time 2 Interview ................... 150 1 45/60 113 

Time 3 Interview ................... 150 1 45/60 113 


lotter on DSK11XQN23PROD with NOTICES1
38100 Federal Register / Vol. 86, No. 135 / Monday, July 19, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Individual Healthcare/First Responder ......... Informed Consent ................. 51,000 2 5/60 8,500 

Baseline Survey .................... 51,000 1 20/60 17,000 

Follow-up Survey .................. 51,000 1 20/60 17,000 

Total ....................................................... ............................................... ........................ ........................ ........................ 42,877 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–15228 Filed 7–16–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–1244; Docket No. CDC–2021– 

0063] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on an 

Extension of a previously approved 

information collection project titled 

Assessment of Occupational Injury 

among Fire Fighters Using a Followback Survey. The purpose of this project 

is to collect follow-back telephone 

interview data from injured and 

exposed firefighters treated in 

emergency departments (EDs) and 

produce a descriptive summary of these 

injuries and exposures. 

DATES: CDC must receive written 

comments on or before September 17, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0063 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Assessment of Occupational Injury 

among Fire Fighters Using a Followback Survey (OMB Control No. 0920– 

1244)—Extension—National Institute 

for Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Studies have reported that firefighters 

have high rates of non-fatal injuries and 

illnesses as compared to the general 

worker population. As firefighters 

perform critical public safety activities 

and protect the safety and health of the 

public, it follows that understanding 

and preventing injuries and exposures 

among firefighters will have a benefit 

reaching beyond the workers to the 

public. 

As mandated in the Occupational 

Safety and Health Act of 1970 (Pub. L. 

91–596), the mission of NIOSH is to 

conduct research and investigations on 

occupational safety and health. Related 

to this mission, the purpose of this 

project is to conduct research that will 

provide a detailed description of nonfatal occupational injuries and 

exposures incurred by firefighters. This 

information will offer detailed insight 

into events that lead to the largest 

number of nonfatal injuries and 

exposures among firefighters. The 

project will use two related data 

sources. The first source is data 

abstracted from medical records of 

firefighters treated in a nationally 

stratified sample of emergency 


lotter on DSK11XQN23PROD with NOTICES1